Smarter Studies
We work to deliver swifter and more effective translation of scientific research into patient benefits
Global Impact
We are at the forefront of resolving internationally important questions
Better Health
Our research helps to improve healthcare around the world
The MRC Clinical Trials Unit at UCL became the UCL Innovative Clinical Trials Unit in April 2026. The Innovative Clinical Trials Unit is continuing the mission of smarter studies and global impact, leading to better health.
Latest News
Global NeoSep1 trial expands to India to tackle neonatal sepsis
The first infant has been enrolled in India as NeoSep1 extends recruitment across the Asia-Pacific region to evaluate antibiotic treatments for neonatal sepsis.
07 Jul
New podcast episode: The ACORD Collaboration: Innovative Clinical Trials for Neurodegenerative Diseases
In this Trial Talk episode, we speak to James Carpenter and Ed Jabbari about the ACORD collaboration and its potential to change the landscape of clinical research in neurodegenerative diseases.
30 Jun
SNAP trial shows safer antibiotic option for staph blood infection
Cefazolin is a better option than flucloxacillin to treat strap blood infections. Also, penicillin can be used instead of flucloxacillin when strap is treatable with this antibiotic in the lab.
18 Jun
Using two immunotherapy drugs together benefits people with kidney cancer
New results from the RAMPART trial found that giving durvalumab alone did not help prevent kidney cancer from coming back after surgery compared to active monitoring.
02 Jun
In 2024, we celebrated our 25th anniversary. That's 25 years of smarter studies, global impact and better health. '25 at 25' is a series of articles highlighting 25 of our major achievements in that time.
Research Themes
Cancer
Innovative clinical trial design and meta-analysis extending beyond the boundaries of single cancer types
Infections
Major international clinical trials answering questions of global public health significance
Neurodegenerative diseases
New generation of innovative multi-arm multi-stage trials to identify and test new therapeutic treatments in neurodegenerative diseases (NDD)
Methodology
Development of methods with direct impact on the design, conduct and analysis of studies
Other Research & Policy
This section will capture projects outside the current QQR themes